Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
twoplus fertility
AddedMar 22, 2024
UpdatedJul 1, 2026
twoplus fertility

twoplus fertility

Seed

Twoplus Fertility: Home-use tech for natural conception, enhancing pregnancy chances.

HQ
Singapore, Singapore, SG
Founded
2019
Accelerator
Y Combinator logoY CombinatorS20
Overview
Compare
Fundraising
Employees
Website

Twoplus fertility offers an innovative home-use fertility treatment for natural conception. Their technology aims to increase the likelihood of pregnancy by guiding a higher number of sperm towards the ovum, using a proprietary combination of surface features and microenvironment optimization. The company's approach allows infertile couples to order and use the treatment at home, providing a more accessible and less stressful alternative to traditional fertility treatments.

The company's flagship product, an FDA-cleared applicator, enables self-assisted home insemination, designed to eliminate stress during sex and maximize attempts per cycle. Twoplus fertility's solution is based on Stanford design principles and is eligible for FSA/HSA coverage. By offering a discreet, user-friendly approach to fertility treatment, the company aims to help couples get pregnant faster and more comfortably in their own homes.

twoplus fertility - Similar Companies

Hannah Life Technologies logo

Hannah Life Technologies

hannahlifetech.com

Hera Fertility logo

Hera Fertility

herafertility.co

zuri fertility logo

zuri fertility

zurifertility.com

OVATEMP logo

OVATEMP

Kindly Health logo

Kindly Health

kindlyhealth.com

Mosie Baby logo

Mosie Baby

mosiebaby.com

Proov logo

Proov

proovtest.com

Future Family logo

Future Family

futurefamily.com

Microgenesis logo

Microgenesis

microgenesis.net

Lilia logo

Lilia

hellolilia.com

Carrot Fertility logo

Carrot Fertility

get-carrot.com

MedAnswers logo

MedAnswers

Conceivable Life Sciences logo

Conceivable Life Sciences

conceivable.life

Sama Fertility logo

Sama Fertility

babyMed logo

babyMed

twoplus fertility - Quick Facts

Who are twoplus fertility's competitors?

Companies similar to twoplus fertility include Hannah Life Technologies, Hera Fertility, zuri fertility and OVATEMP.

When was twoplus fertility founded?

twoplus fertility was founded in 2019.

Where is twoplus fertility's headquarters located?

twoplus fertility's headquarters is located in Singapore, Singapore, SG.

When was twoplus fertility's last funding round?

twoplus fertility's most recent funding round was for $150k (USD) in August 2020.

How much has twoplus fertility raised to-date?

As of Aug 22, 2020, twoplus fertility has raised a total of $150k (USD).

How many employees does twoplus fertility have?

twoplus fertility has 23 employees as of Feb 24, 2024.

twoplus fertility - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Fertility Treatment
Tags
  • eCommerce
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 5 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services